BioHealth News
Israel’s Biolojic Design Joins Johnson & Johnson Innovation – JLABS @ Washington
REHOVOT, Israel and WASHINGTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to…
Read More
Maryland’s IonQ to Advance Hybrid Quantum Computing with New Chemistry Application and NVIDIA CUDA-Q
November 18, 2024 01:30 PM Eastern Standard Time - COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leader in the quantum computing and networking industry, announced…
Read More
NIH Office of Technology Transfer Seeks Deputy Director to Lead Licensing Operation
The NIH Office of Technology Transfer is recruiting for a Deputy Director (GS-15 level) to lead its License Compliance and Administration Unit. This critical…
Read More
BHI EIR Anna Zornosa on ARPA-H Awards: All Women Are Winners
By BHI EIR Anna Zornosa - On October 24th, Arpa-H announced the 23 winners of its “Sprint for Women’s Health” initiative. I’ve had a…
Read More
Cracking the Code of Microbiome Research with Cerillo’s Eric Mayton on BioTalk
[vc_row type="in_container" full_screen_row_position="middle" column_margin="default" column_direction="default" column_direction_tablet="default" column_direction_phone="default" scene_position="center" text_color="dark" text_align="left" row_border_radius="none" row_border_radius_applies="bg" overlay_strength="0.3" gradient_direction="left_to_right" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding" column_padding_tablet="inherit" column_padding_phone="inherit" column_padding_position="all" column_element_spacing="default" background_color_opacity="1" background_hover_color_opacity="1" column_shadow="none"…
Read More
Johnson & Johnson’s Nipocalimab Shows Promising Results in Sjögren’s Disease Phase 2 Study
WASHINGTON, D.C., (November 14, 2024) – Johnson & Johnson (NYSE: JNJ) today announced results from additional analyses of the Phase 2 DAHLIAS study highlighting improvement in key…
Read More
Montgomery County Executive Marc Elrich Announces MOVE Grants Now Available to Businesses Expanding or Moving to the County
For Immediate Release: Thursday, November 14, 2024 - Montgomery County Executive Marc Elrich today announced the launch of the updated MOVE Grant Program to reduce…
Read More
Applications Now Open for 2025 Maryland Stem Cell Research Fund Grant Programs
MSCRF invites applications across seven key grant programs to propel innovation in regenerative medicine COLUMBIA, Md. (November 14, 2024) - The Maryland Stem Cell…
Read More
BHI Welcomes Three New Members to its Board of Directors
ROCKVILLE, MARYLAND, November 14, 2024 – BioHealth Innovation, Inc. (BHI), a public-private nonprofit organization dedicated to accelerating the commercialization of healthcare solutions in the…
Read More
TEDCO Invests in NextStep Robotics
COLUMBIA, Md., (November 12, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Seed Funds investment in NextStep Robotics. TEDCO’s Seed Funds aim to…
Read More
“Ascend Advanced Therapies Expands U.S. Presence with Acquisition of Maryland’s ABL, Backed by EW Healthcare Partners
LONDON, Nov. 12, 2024 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capabilities of the company…
Read More
Regional startups find support at annual GMU Accelerate Investor Conference
The Accelerate Investor Conference spurs the region’s innovation and startup ecosystem engagement to a new level and showcases the Virginia, Maryland, and metropolitan Washington,…
Read More
Updated Save the Date, Mark your calendars now. 11th Annual BioHealth Capital Region Week Rescheduled for September 23-25, 2025!
The 11th Annual BioHealth Capital Region Week has been rescheduled to take place from September 23rd through 25th, 2025, at USP in Rockville, Maryland.…
Read More
U.S. FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S.…
Read More
Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity
GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the successful completion of its End-of-Phase 2 Meeting…
Read More